The influence of inducible costimulator fusion protein (ICOSIg) gene transfer on corneal allograft survival

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 10, 2007, Pages 1515-1521

  Fabian, Daniel ^a   Gong, Nianqiao ^a   Vogt, Katrin ^a   Volk, Hans Dieter ^a   Pleyer, Uwe ^a   Ritter, Thomas ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adenovirus; Cornea; Gene therapy; ICOSIg; Immunomodulation; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INDUCIBLE COSTIMULATOR FUSION PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; EX VIVO GENE TRANSFER; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; IMMUNOMODULATION; IN VIVO GENE TRANSFER; LEWIS RAT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPERNATANT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CORNEA; CORNEAL TRANSPLANTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT SURVIVAL; IMMUNOGLOBULIN G; ORGAN CULTURE TECHNIQUES; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548720928     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0629-y     Document Type: Article

References (35)

1. Khoury SJ, Sayegh MH (2004) The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20:529-538
2. Clarkson MR, Sayegh MH (2005) T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 80:555-563
3. Jenkins MK, Schwartz RH (1987) Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165:302-319
4. Bluestone JA, St Clair EW, Turka LA (2006) CTLA4Ig: Bridging the basic immunology with clinical application. Immunity 24:233-238
5. Lin H, Rathmell JC, Gray GS et al (1998) Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 188:199-204
6. Yamada A, Kishimoto K, Dong VM et al (2001) CD28-independent costimulation of T cells in alloimmune responses. J Immunol 167:140-146
7. Hutloff A, Dittrich AM, Beier KC et al (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263-266
8. Carreno BM, Collins M (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20:29-53
9. Rottman JB, Smith T, Tonra JR et al (2001) The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2:605-611
10. Kosuge H, Suzuki J, Gotoh R et al (2003) Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 75:1374-1379
11. Guo L, Fujino M, Kimura H et al (2003) Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transpl Immunol 12:41-48
12. Guo L, Li XK, Enosawa S et al (2004) Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transpl 10:743-747
13. Harada H, Salama AD, Sho M et al (2003) The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 112:234-243
14. Watson MP, George AJ, Larkin DF (2006) Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci 47:3417-3422
15. Pleyer U, Dannowski H, Volk HD et al (2001) Corneal allograft rejection: current understanding. I. Immunobiology and basic mechanisms. Ophthalmologica 215:254-262
16. George AJT, Larkin DFP (2004) Corneal transplantation: The forgotten graft. Am J Transplant 4:678-685
17. Coster DJ, Williams KA (2005) The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140:1112-1122
18. Larkin DF, Oral HB, Ring CJ et al (1996) Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 61:363-370
19. Ritter T, Vogt K, Rieck P et al (1999) Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 69:563-568
20. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33-40
21. Hoffmann F, Zhang EP, Pohl T et al (1997) Inhibition of corneal allograft reaction by CTLA4-Ig. Graefes Arch Clin Exp Ophthalmol 235:535-540
22. König Merediz SA, Zhang EP, Wittig B et al (2000) Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation. Graefes Arch Clin Exp Ophthalmol 238:701-707
23. Comer RM, King WJ, Ardjomand N et al (2002) Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 43:1095-1103
24. Ardjomand N, McAlister JC, Rogers NJ et al (2003) Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci 44:3899-3905
25. Thiel MA, Steiger JU, O'Connell PJ et al (2005) Local or short-term systemic costimulatory molecule blockade prolongs rat corneal allograft survival. Clin Experiment Ophthalmol 33:176-180
26. Gong N, Pleyer U, Yang J et al (2006) Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival. J Gene Med 8:459-467
27. Kolls J, Peppel K, Silva M et al (1994) Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91:215-219
28. Matsui Y, Okamoto H, Inobe M et al (2003) Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis. Hum Gene Ther 14:521-532
29. Wang S, Zhu G, Tamada K et al (2002) Ligand binding sites of inducible costimulator and high avidity mutants with improved function. J Exp Med 195:1033-1041
30. Yang Y, Li Q, Ertl HC et al (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015
31. Bennett J, Pakola S, Zeng Y et al (1996) Humoral response after administration of E1-deleted adenoviruses: Immune privilege of the subretinal space. Hum Gene Ther 7:1763-1769
32. Gong N, Pleyer U, Volk H-D et al (2007) Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival. Gene Ther 14:484-490
33. Campochiaro PA, Nguyen QD, Shah SM et al (2006) Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial. Hum Gene Ther 17:167-176
34. Huard J, Lochmuller H, Acsadi G et al (1995) The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
35. Gong N, Pleyer U, Vogt K et al (2007) Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival. Invest Ophthalmol Vis Sci 48:1043-1052